Efficacy of folic acid as an adjunct to lithium therapy on manic-like behaviors, oxidative stress and inflammatory parameters in an animal model of mania.
Amphetamine
/ toxicity
Animals
Antimanic Agents
/ administration & dosage
Central Nervous System Stimulants
/ toxicity
Disease Models, Animal
Drug Therapy, Combination
Folic Acid
/ administration & dosage
Inflammation Mediators
/ antagonists & inhibitors
Lithium
/ administration & dosage
Male
Mania
/ chemically induced
Oxidative Stress
/ drug effects
Rats
Rats, Wistar
Treatment Outcome
Animal model of mania
Bipolar disorder
Folic acid
M-amphetamine
Journal
Metabolic brain disease
ISSN: 1573-7365
Titre abrégé: Metab Brain Dis
Pays: United States
ID NLM: 8610370
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
12
06
2019
accepted:
01
10
2019
pubmed:
17
12
2019
medline:
30
1
2021
entrez:
17
12
2019
Statut:
ppublish
Résumé
Evaluate the efficacy of folic acid (FA) as a therapeutic adjunct to lithium (Li) on the manic-like behaviors as well as parameters of oxidative stress and inflammation in an animal model of mania induced by m-amphetamine (m-AMPH). Wistar rats first received m-AMPH or saline (NaCl 0.9%, Sal) for 14 days. Between the 8th and 14th day, rats were treated with water, Li, FA or a combination of thereof drugs (Li + FA). Manic-like behaviors were assessed in the open-field test. Oxidative stress and inflammation parameters were assessed in the frontal cortex, striatum, and hippocampus. Administration of m-AMPH in rats significantly enhanced the exploratory and locomotor behaviors, as well as the risk-taking and stereotypic behaviors. Li + FA reversed these behavioral alterations elicited by m-AMPH. Administration of this psychostimulant also increased oxidative damage to lipids and proteins, whereas Li + FA reversed these oxidative damages. m-AMPH also induced an increase in the glutathione peroxidase (GPx) activity and a decrease in the glutathione reductase (GR) activity. Li + FA reversed the alteration in GR activity, but not in GPx activity. In addition, m-AMPH increased the IL-1β and TNF-α levels in the rat brain; Li + FA combined therapy reversed the alterations on these inflammatory parameters. FA administration per se reduced the increased TNF-α content induced by m-AMPH. Present study provides evidence that FA is effective as an adjunct to Li standard therapy on manic-like behaviors, oxidative stress and inflammatory parameters in a model of mania induced by m-AMPH.
Identifiants
pubmed: 31840201
doi: 10.1007/s11011-019-00503-3
pii: 10.1007/s11011-019-00503-3
doi:
Substances chimiques
Antimanic Agents
0
Central Nervous System Stimulants
0
Inflammation Mediators
0
Folic Acid
935E97BOY8
Lithium
9FN79X2M3F
Amphetamine
CK833KGX7E
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
413-425Références
Health Technol Assess. 2014 Jul;18(48):vii-viii, 1-159
pubmed: 25052890
Bipolar Disord. 2001 Apr;3(2):68-72
pubmed: 11333065
Pharm Biol. 2017 Dec;55(1):1295-1303
pubmed: 28274156
J Affect Disord. 1986 Jan-Feb;10(1):9-13
pubmed: 2939126
J Psychiatr Res. 1989;23(2):157-62
pubmed: 2511299
Int J Neuropsychopharmacol. 2018 Jun 1;21(6):550-569
pubmed: 29596661
Depress Anxiety. 2014 May;31(5):379-90
pubmed: 24353094
J Clin Psychopharmacol. 2017 Feb;37(1):40-45
pubmed: 27902528
Neurosci Biobehav Rev. 2011 Jan;35(3):804-17
pubmed: 20934453
Proc Nutr Soc. 2017 Nov;76(4):427-436
pubmed: 28942748
Expert Opin Ther Targets. 2015 Jul;19(7):927-39
pubmed: 25882812
Pharmacol Biochem Behav. 2012 Mar;101(1):148-54
pubmed: 22227220
Clin Pharmacokinet. 2017 Jan;56(1):77-90
pubmed: 27393139
Neurosci Lett. 2012 Nov 14;530(1):75-9
pubmed: 23022501
Bipolar Disord. 2010 Jun;12(4):414-24
pubmed: 20636639
Aust N Z J Psychiatry. 2013 Nov;47(11):1013-8
pubmed: 23969624
Mol Psychiatry. 2015 Jun;20(6):661-70
pubmed: 25687772
Pediatr Neurol. 2007 Dec;37(6):387-97
pubmed: 18021918
Br J Psychiatry. 1982 Jul;141:87-9
pubmed: 7116078
Lancet Psychiatry. 2016 Jan;3(1):31-39
pubmed: 26687300
Xenobiotica. 2014 May;44(5):480-8
pubmed: 24494987
Bipolar Disord. 2018 Dec;20(8):733-745
pubmed: 30375699
Curr Psychiatry Rep. 2015 Feb;17(2):8
pubmed: 25620790
Pharmacol Biochem Behav. 2019 Aug;183:56-63
pubmed: 31158395
J Psychiatr Res. 2014 Mar;50:36-41
pubmed: 24332923
Lancet. 2016 Apr 9;387(10027):1561-1572
pubmed: 26388529
Acta Psychiatr Scand. 2009 Dec;120(6):441-5
pubmed: 19392814
Int J Bipolar Disord. 2017 Oct 13;5(1):35
pubmed: 29027157
Arch Gen Psychiatry. 2011 Mar;68(3):241-51
pubmed: 21383262
Neurosci Biobehav Rev. 2014 Nov;47:307-20
pubmed: 25173634
Bipolar Disord. 2017 Sep;19(6):477-486
pubmed: 28833962
Cardiovasc Toxicol. 2011 Mar;11(1):67-73
pubmed: 21076891
Cell Mol Neurobiol. 2011 Jan;31(1):83-91
pubmed: 21170581
Behav Brain Res. 2014 Apr 1;262:94-100
pubmed: 24445072
Braz J Psychiatry. 2013;35 Suppl 2:S121-31
pubmed: 24271224
J Neural Transm (Vienna). 2012 Jan;119(1):31-8
pubmed: 21858431
Mol Neurobiol. 2019 Jan;56(1):141-156
pubmed: 29681025
J Neurochem. 2019 Mar;148(6):779-795
pubmed: 30556914
Psychother Psychosom. 2013;82(1):10-9
pubmed: 23147067
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Apr 3;66:22-34
pubmed: 26545487
Bipolar Disord. 2006 Jun;8(3):275-80
pubmed: 16696830
Brain Res. 2005 Nov 9;1061(2):114-7
pubmed: 16256963
Int J Dev Neurosci. 2007 Dec;25(8):545-52
pubmed: 18023318
Int J Bipolar Disord. 2014 Dec 20;2:15
pubmed: 25530932
Eur Psychiatry. 2017 Jun;43:81-91
pubmed: 28371745
J Affect Disord. 1997 Nov;46(2):95-9
pubmed: 9479613
Trends Neurosci. 2003 Mar;26(3):137-46
pubmed: 12591216
Bipolar Disord. 2015 Aug;17(5):507-17
pubmed: 25929806
Altern Med Rev. 2008 Sep;13(3):216-26
pubmed: 18950248
J Affect Disord. 2017 Jan 01;207:429-433
pubmed: 27794238
Australas Psychiatry. 2017 Aug;25(4):369-372
pubmed: 28135835
Mol Chem Neuropathol. 1997 May;31(1):65-72
pubmed: 9271006
J Psychopharmacol. 2005 Jan;19(1):59-65
pubmed: 15671130
J Biol Chem. 1951 Nov;193(1):265-75
pubmed: 14907713
Transl Psychiatry. 2019 Jun 4;9(1):158
pubmed: 31164628
Mol Genet Metab. 2000 Sep-Oct;71(1-2):121-38
pubmed: 11001804
Bioinform Biol Insights. 2018 Dec 11;12:1177932218815152
pubmed: 30559594
Pharmacol Biochem Behav. 2013 Jan;103(3):589-96
pubmed: 23010382